**Abbreviations**


**References**

[1] Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, et al. Global burden of cancer in 2008: A systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012;**380**:1840-1850. DOI: 10.1016/S0140-6736(12)60919-2

Signaling Pathways Related to Nerve Growth Factor and miRNAs in Epithelial Ovarian Cancer

http://dx.doi.org/10.5772/intechopen.73804

49

[2] Lowe KA, Chia VM, Taylor A, O'Malley C, Kelsh M, Mohamed M, et al. An international assessment of ovarian cancer incidence and mortality. Gynecologic Oncology.

[3] Iruela-Arispe ML, Dvorak HF. Angiogenesis: A dynamic balance of stimulators and

[4] Suzuki T, Sasano H, Takaya R, Fukaya T, Yajima A, Nagura H. Cyclic changes of vasculature and vascular phenotypes in normal human ovaries. Human Reproduction.

[5] Carmeliet P. Angiogenesis in health and disease: Therapeutic opportunities. Nature

[6] Mobley WC, Schenker A, Shooter EM. Characterization and isolation of proteolytically

[7] Sariola H. The neurotrophic factors in non-neuronal tissues. Cellular and Molecular Life

[8] Friedman WJ, Greene LA. Neurotrophin signaling via Trks and p75. Experimental Cell

[9] Patapoutian A, Reichardt LF. Trk receptors: Mediators of neurotrophin action. Current Opinion in Neurobiology. 2001;**11**:272-280. DOI: 10.1016/S0959-4388(00)00208-7

[10] Bibel M, Hoppe E, Barde YA. Biochemical and functional interactions between the neurotrophin receptors trk and p75(NTR). The EMBO Journal. 1999;**18**:616-622. DOI:

[11] Tessarollo L. Pleiotropic functions of neurotrophins in development. Cytokine & Growth

[12] Yuan J, Yankner BA. Apoptosis in the nervous system. Nature. 2000;**407**:802-809. DOI:

[13] Underwood CK, Coulson EJ. The p75 neurotrophin receptor. The International Journal of Biochemistry & Cell Biology. 2008;**40**:1664-1668. DOI: 10.1016/j.biocel.2007.06.010

[14] Lee FS, Kim AH, Khursigara G, Chao MV. The uniqueness of being a neurotrophin receptor. Current Opinion in Neurobiology. 2001;**11**:281-286. DOI: 10.1016/S0959-4388

Factor Reviews. 1998;**9**:125-137. DOI: 10.1016/S1359-6101(98)00003-3

2013;**130**:107-114. DOI: 10.1016/j.ygyno.2013.03.026

1998;**13**:953-959. DOI: 10.1093/humrep/13.4.953

Medicine. 2003;**9**:653-660. DOI: 10.1038/nm0603-653

Sciences. 2001;**58**:1061-1066. DOI: 10.1007/PL00000921

Research. 1999;**253**:131-142. DOI: 10.1006/excr.1999.4705

10.1093/emboj/18.3.616

10.1038/35037739

(00)00209-9

modified nerve growth factor. Biochemistry. 1976;**15**:5543-5552

inhibitors. Thrombosis and Haemostasis. 1997;**78**:672-677
